Clinical Characteristics and Outcomes of Early‐Onset Versus Late‐Onset LGI1‐Antibody Encephalitis
ABSTRACT Background Leucine‐rich glioma‐inactivated 1 antibody (LGI1‐Ab) encephalitis predominantly affected older individuals, but has also been reported in younger patients. However, the demographic, clinical, and prognostic characteristics of early‐onset LGI1‐Ab encephalitis have yet to be systematically elucidated. This study aims to systematically
Yu Kong +7 more
wiley +1 more source
ABSTRACT Background Apolipoprotein ε4 (APOE ε4) is a potent genetic risk factor for Alzheimer's disease (AD). However, its role in cerebral small vessel disease (CSVD) remains unclear. Given the clinical and pathological similarities between CSVD and AD, this study aimed to investigate the associations of APOE ε4 gene dosage with cognitive function and
Tingru Jin +6 more
wiley +1 more source
New insights into automatic treatment planning for cancer radiotherapy using explainable artificial intelligence. [PDF]
Mainul Abrar M, Jia X, Chi Y.
europepmc +1 more source
THE EFFECTS OF SOCIAL APPROVAL NEEDS ON THE PRESENTATION OF CAUSAL ATTRIBUTIONS
Yasuko Morinaga
openalex +2 more sources
Amyotrophic Lateral Sclerosis Prevalence Projection in 2040: A Less Rare Disease
ABSTRACT Objective To project ALS prevalence across multiple countries through 2040, accounting for both population aging and increased survival. Methods Data from the Piemonte and Valle d'Aosta ALS register (PARALS) was used to estimate the trends in incidence and prevalence from 2005 to 2019. Survival trends over this period were also assessed.
Rosario Vasta +18 more
wiley +1 more source
Separate and unequal: Moral domains differ in corresponding social judgments of others. [PDF]
Adams S, Ybarra O.
europepmc +1 more source
LITES-based methane isotope ratio measurement and source attribution
Yifan Chen +12 more
openalex +1 more source
The possible attribution of abnormal lipid concentrations in Heart Failure: A comparative study.
Dr Rajendra Kumar, Dr Prodeep Kumar
openalex +2 more sources
ABSTRACT Background There is growing recognition of the potential of plasma proteomics for Alzheimer's Disease (AD) risk assessment and disease characterization. However, differences between proteomics platforms introduce uncertainties regarding cross‐platform applicability.
Manyue Hu +9 more
wiley +1 more source
Are you willing to forgive generative AI doctors? Trust repair after failures in online health consultation services. [PDF]
Chen Y, Luo S, Yin Y.
europepmc +1 more source

